Related Experiment Video

Updated: Jul 30, 2026

Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural

H-H Yeh1, W-W Lai, H H W Chen

  • 1Institute of Basic Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Oncogene
|March 7, 2006
PubMed

Insights

Activated Stat3 signaling in adenocarcinoma cell lung cancer (ADCLC) promotes malignant pleural effusion (MPE) by upregulating vascular endothelial growth factor (VEGF). This pathway offers new therapeutic targets for MPE management.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Malignant pleural effusion (MPE) is a significant indicator of poor prognosis in non-small-cell lung cancer (NSCLC).
  • Vascular endothelial growth factor (VEGF) plays a key role in MPE development, with its upregulation linked to Stat3 activation in various tumor cells.

Purpose of the Study:

  • To investigate the role of activated Signal Transducer and Activator of Transcription 3 (Stat3) in the pathogenesis of adenocarcinoma cell lung cancer (ADCLC) and MPE.
  • To elucidate the IL-6/Stat3/VEGF signaling pathway in ADCLC and its association with MPE.

Main Methods:

  • Demonstrated constitutive Stat3 activation in human ADCLC cell lines and patient tumor samples.
  • Utilized cell lines (PC14PE6/AS2 and Stat3-negative PC14PE6/AS2/dnStat3) to study IL-6-mediated Stat3 activation via JAKs.
  • Employed an animal model to assess the impact of Stat3 inhibition on MPE and metastasis.
  • Measured IL-6 and VEGF levels in pleural fluids from ADCLC patients and those with congestive heart failure.

Main Results:

  • Activated Stat3 was observed in ADCLC cell lines and pleural tumor cells from patients with MPE.
  • Autocrine IL-6 activated Stat3 in PC14PE6/AS2 cells, leading to increased VEGF expression.
  • Stat3 inhibition in vivo reduced MPE formation and lung metastasis, with decreased tumor microvessel density and vascular permeability.
  • Elevated IL-6 and VEGF levels were detected in the pleural fluids of ADCLC patients compared to heart failure patients.

Conclusions:

  • Constitutively activated Stat3 plays a role in ADCLC pathogenesis and MPE development.
  • The autocrine IL-6/Stat3/VEGF signaling pathway is implicated in MPE formation in ADCLC.
  • Targeting the IL-6/Stat3/VEGF pathway presents a potential therapeutic strategy for managing MPE in ADCLC patients.

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...